Novel Oral Anticoagulants (NOACs) Roundtable – Hot Topics and Current Issues in association with Arrhythmia & Electrophysiology Review | Zendy

A. John Camm | Zendy; Marco Alings | Zendy; Raffaele De Caterina | Zendy; Paulus Kirchhof | Zendy; JeanYves Le Heuzey | Zendy; Freek W.A. Verheugt | Zendy

Open Access

Novel Oral Anticoagulants (NOACs) Roundtable – Hot Topics and Current Issues in association with Arrhythmia & Electrophysiology Review

Author(s) -

A. John Camm,

Marco Alings,

Raffaele De Caterina,

Paulus Kirchhof,

JeanYves Le Heuzey,

Freek W.A. Verheugt

Publication year - 2015

Publication title -

arrhythmia and electrophysiology review

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.008

H-Index - 18

eISSN - 2050-3377

pISSN - 2050-3369

DOI - 10.15420/aer.2015.4.1.sup1

Subject(s) - dosing , medicine , atrial fibrillation , vitamin k antagonist , intensive care medicine , clinical practice , family medicine , warfarin

On 12 November 2014, Radcliffe Cardiology, in association with Arrhythmia & Electrophysiology Review (AER) journal, held a roundtable discussion in London, UK. The discussion held between an expert group of physicians was moderated by Professor A John Camm, a renowned authority in anticoagulation and atrial fibrillation. The meeting comprised a series of seven presentations and subsequent panel discussions on a range of topical issues related to the use of non-vitamin K antagonist (novel) oral anticoagulants (NOACs): real-world versus clinical trial data; once or twice daily dosing regimens; spot checks or monitoring for anticoagulation status; antidotes for NOACs; NOACs and dual antiplatelet therapy; NOAC treatment in chronic renal impairment; and choosing between NOACs. This paper summarises the presentations and presents key highlights from the subsequent discussions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research